(HealthDay)—Certain nonpharmacologic treatments are effective in pediatric abdominal pain-related functional gastrointestinal disorders (AP-FGIDs), according to a review published online Feb. 9 in Pediatrics.
Feb 9, 2015
0
5
Going to the hospital can save your life, but it is not without risks. Patients can be exposed to dangerous infections while receiving treatment. In the United States, health care-associated infections are the fifth leading ...
Nov 6, 2014
0
0
(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).
Oct 16, 2014
0
0
The temperature for the first person to die of Ebola in the United States spiked to 103 degrees (39.4 Celsius) during the hours of his initial visit to an emergency room—a fever that was flagged with an exclamation point ...
Oct 10, 2014
1
0
Here are some facts about how Ebola spreads:
Oct 9, 2014
0
0
(HealthDay)—Movantik (naloxegol) has been approved by the U.S. Food and Drug Administration to treat opioid-induced constipation, the agency said Tuesday.
Sep 16, 2014
0
0
(HealthDay)—Florida health officials are cautioning visitors to the state's beaches about the threat of Vibrio vulnificus bacteria in warm seawater this summer.
Aug 1, 2014
0
0
Implementation of an algorithm aimed to diagnose pediatric patients with suspected appendicitis reduces the utilization of computed tomography (CT) scans, without affecting diagnostic accuracy, Mayo Clinic Children's Center ...
Aug 1, 2014
0
0
(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...
Jul 24, 2014
0
0
(Medical Xpress)—The first indication that you're sick is typically one or more symptoms: perhaps a cough, fever, abdominal pain, etc. Symptoms are high-level clinical manifestations of a disease that, at a lower level, ...
